Adiposopathy and epigenetics: An introduction to obesity as a transgenerational disease

Current Medical Research and Opinion

Volumn 31, Issue 11, 2015, Pages 2059-2069

  Bays, Harold ^a   Scinta, Wendy ^b,c  

^a LOUISVILLE METABOLIC AND ATHEROSCLEROSIS RESEARCH CENTER   (United States)

^b Medical Weight Loss of New York   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Adiposopathy; Epigenetics; Obesity; Transgenerational

Indexed keywords

MELANOCORTIN 4 RECEPTOR;

ADIPOCYTE; ADIPOSE TISSUE; BARDET BIEDL SYNDROME; BINGE EATING DISORDER; BODY FAT; BULIMIA; EATING DISORDER; EMOTION; ENERGY CONSUMPTION; EPIGENETICS; FAT MASS; FATIGUE; GENE EXPRESSION; GENETIC CODE; GENETIC DISORDER; HUMAN; LIPID STORAGE; MENTAL STRESS; METABOLIC DISORDER; MUSCULOSKELETAL PAIN; OBESITY; OSTEODYSTROPHY; PHYSICAL ACTIVITY; PRADER WILLI SYNDROME; REVIEW; WEIGHT REDUCTION; BODY WEIGHT; GENETICS;

ADIPOSITY; BODY WEIGHT; HUMANS; OBESITY;

EID: 84947487454     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2015.1087983     Document Type: Review

References (85)

1. Seger JC, Horn DB, Westman EC, et al. Obesity Algorithm. American Society of Bariatric Physicians website: American Society of Bariatric Physicians, 2014
2. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-7
3. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311: 806-14
4. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-209
5. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity among adults: United States, 2011-2012. NCHS Data Brief 2013; 131: 1-8
6. U.S. Department of Health and Human Resources. Centers for Disease Control and Prevention. National Center for Health Services. Available at: http://www.cdc.gov/nchs/data/hus/hus09.pdf. Accessed 12 September 2015
7. World Health Organization. Obesity and overweight Fact sheet N°311. Updated January 2015. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 12 September 2015
8. Dobbs R, Sawers C, Thompson F, et al. Overcoming obesity: an initial economic analysis. McKinsey Global Institute. Available at: http://www.healthyweightcommit.org/images/uploads/MGI-Obesity-Full-report-November-2014.pdf. Accessed 12 September 2015
9. Bays H. Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction. Curr Opin Endocrinol Diabetes Obes 2014; 21: 345-51
10. Bays H. Adiposopathy, Sick fat, Ockhams razor, and resolution of the obesity paradox. Curr Atherosclerosis Rep 2014; 16: 409
11. McCrindle BW. The contribution of anthropometry, adiposity, and adiposopathy to cardiometabolic disturbances in obese youth. J Pediatr 2014; 165: 1083-4
12. McCrindle BW. Cardiovascular consequences of childhood obesity. Can J Cardiol 2015; 31: 124-30
13. Rosen CJ, Ingelfinger JR. Unraveling the function of FTO variants. N Engl J Med 2015; 373: 964-5
14. Claussnitzer M, Dankel SN, Kim KH, et al. FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 2015; 373: 895-907
15. Alsters SI, Goldstone AP, Buxton JL, et al. Truncating homozygous mutation of carboxypeptidase E (CPE) in a morbidly obese female with type 2 diabetes mellitus, intellectual disability and hypogonadotrophic hypogonadism. PloS One 2015; 10: e0131417
16. Farooqi IS, O'Rahilly S. Genetic obesity syndromes. In: Grant SFA., ed. The Genetics of Obesity. New York: Springer Science + Business Media, 2014: 23-32
17. Herrera BM, Keildson S, Lindgren CM. Genetics and epigenetics of obesity. Maturitas 2011; 69: 41-9
18. Stutzmann F, Tan K, Vatin V, et al. Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes 2008; 57: 2511-18
19. Ramachandrappa S, Farooqi IS. Genetic approaches to understanding human obesity. J Clin Invest 2011;121:2080-6
20. Goldstone AP, Beales PL. Genetic obesity syndromes. Front Horm Res 2008; 36: 37-60
21. Forsythe E, Beales PL. Bardet-Biedl syndrome. Eur J Hum Genet 2013; 21: 8-13
22. Donadieu J, Fenneteau O, Beaupain B, et al. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis 2011; 6: 26
23. Budisteanu M, Barca D, Chirieac SM, Magureanu S. Cohen syndrome-A rare genetic cause of hypotonia in children. Maedica (Buchar) 2010; 5: 56-61
24. Gécz J, Turner G, Nelson J, Partington M. The Börjeson-Forssman-Lehman syndrome (BFLS, MIM #301900). Eur J Hum Genet 2006; 14: 1233-7
25. Genetic Alliance. Understanding Genetics: A District of Columbia Guide for Patients and Health Professionals. 2010. Available at: http://www.geneticalliance.org/publications/understandinggenetics. Accessed 12 September 2015
26. Lodish H, Berk A, Zipursky S, et al. Molecular Cell Biology, 4th edn. WH Freeman Publishers, 2000
27. Farooqi IS, Yeo GS, Keogh JM, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106: 271-9
28. Germain DP. General aspects of X-linked diseases. In: Mehta A, Beck M, Sunder-Plassmann G., eds. Fabry Disease: Perspectives from 5 Years of FOS. Newtown, PA: Oxford PharmaGenesis, 2000
29. Youngson NA, Morris MJ. What obesity research tells us about epigenetic mechanisms. Philos Trans R Soc Lond B Biol Sci 2013; 368: 20110337
30. Martinez-Jimenez CP, Sandoval J. Epigenetic crosstalk: a molecular language in human metabolic disorders. Front Biosci (Schol Ed) 2015; 7: 46-57
31. Keane E, Layte R, Harrington J, et al. Measured parental weight status and familial socio-economic status correlates with childhood overweight and obesity at age 9. PLoS One 2012; 7: e43503
32. Lifshitz F. Obesity in children. J Clin Res Pediatr Endocrinol 2008; 1: 53-60
33. Lavebratt C, Almgren M, Ekström TJ. Epigenetic regulation in obesity. Int J Obes (Lond) 2012; 36: 757-65
34. Godfrey KM, Costello PM, Lillycrop KA. The developmental environment, epigenetic biomarkers and long-Derm health. J Dev Orig Health Dis 2015; 6: 399-406
35. Simmons R. Epigenetics and maternal nutrition: nature v. nurture. Proc Nutr Soc 2011; 70: 73-81
36. Lecoutre S, Breton C. Maternal nutritional manipulations program adipose tissue dysfunction in offspring. Front Physiol 2015; 6: 158
37. Wu J, Jun H, McDermott JR. Formation and activation of thermogenic fat. Trends Genet 2015; 31: 232-8
38. Guo L, Li X, Tang QQ. Transcriptional regulation of adipocyte differentiation: a central role for CCAAT/enhancer-binding protein (C/EBP) beta. J Biol Chem 2015; 290: 755-61
39. Lee JE, Ge K. Transcriptional and epigenetic regulation of PPARgamma expression during adipogenesis. Cell Biosci 2014; 4: 29
40. Toubal A, Treuter E, Clement K, Venteclef N. Genomic and epigenomic regulation of adipose tissue inflammation in obesity. Trends Endocrinol Metabol 2013; 24: 625-34
41. Chase K, Sharma RP. Epigenetic developmental programs and adipogenesis: implications for psychotropic induced obesity. Epigenetics 2013; 8: 1133-40
42. Ross MG, Desai M. Developmental programming of offspring obesity, adipogenesis, and appetite. Clin Obstet Gynecol 2013; 56: 529-36
43. Houde AA, Hivert MF, Bouchard L. Fetal epigenetic programming of adipokines. Adipocyte 2013; 2: 41-6
44. Kalish JM, Jiang C, Bartolomei MS. Epigenetics and imprinting in human disease. Int J Dev Biol 2014; 58: 291-8
45. Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 2015. [Epub ahead of print]. doi: 10.1007/s40618-015-0312-9
46. Buiting K, Gross S, Lich C, et al. Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am J Hum Genet 2003; 72: 571-7
47. Desai M, Jellyman JK, Ross MG. Epigenomics, gestational programming and risk of metabolic syndrome. Int J Obes (Lond) 2015; 39: 633-41
48. Janesick A, Blumberg B. Obesogens, stem cells and the developmental programming of obesity. Int J Androl 2012; 35: 437-48
49. Stel J, Legler J. The role of epigenetics in the latent effects of early life exposure to obesogenic endocrine disrupting chemicals. Endocrinology 2015: en20151434. [Epub ahead of print]. doi: http://dx.doi.org/10.1210/en.2015-1434
50. McMillen IC, Rattanatray L, Duffield JA, et al. The early origins of later obesity: pathways and mechanisms. Adv Exp Med Biol 2009; 646: 71-81
51. McMillen IC, MacLaughlin SM, Muhlhausler BS, et al. Developmental origins of adult health and disease: the role of periconceptional and foetal nutrition. Basic Clin Pharmacol Toxicol 2008; 102: 82-9
52. Muhlhausler BS, Gugusheff JR, Ong ZY, Vithayathil MA. Nutritional approaches to breaking the intergenerational cycle of obesity. Can J Physiol Pharmacol 2013; 91: 421-8
53. Curley JP, Mashoodh R, Champagne FA. Epigenetics and the origins of paternal effects. Horm Behav 2011; 59: 306-14
54. Skinner MK, Guerrero-Bosagna C, Haque MM. Environmentally induced epigenetic transgenerational inheritance of sperm epimutations promote genetic mutations. Epigenetics 2015; 10: 762-71
55. Aiken CE, Ozanne SE. Transgenerational developmental programming. Human reproduction update 2014; 20: 63-75
56. Skinner MK, Manikkam M, Tracey R, et al. Ancestral dichlorodiphenyltrichloroethane (DDT) exposure promotes epigenetic transgenerational inheritance of obesity. BMC Med 2013; 11: 228
57. Rissman EF, Adli M. Minireview: transgenerational epigenetic inheritance: focus on endocrine disrupting compounds. Endocrinology 2014; 155: 2770-80
58. (NIEHS) NIoEHS. Endocrine Disruptors. NIEHS website fact sheet: Research Triangle Park, NC: National Institutes of Health, 2010. Available at: https://www.niehs.nih.gov/health/materials/endocrine-disruptors-508.pdf. Accessed 12 September 2015
59. van Dijk SJ, Molloy PL, Varinli H, et al. Epigenetics and human obesity. Int J Obes (Lond) 2015;39:85-97
60. Thompson N, Huber K, Bedurftig M, et al. Metabolic programming of adipose tissue structure and function in male rat offspring by prenatal undernutrition. Nutr Metab (Lond) 2014; 11: 50
61. Muhlhausler BS, Adam CL, McMillen IC. Maternal nutrition and the programming of obesity: the brain. Organogenesis 2008; 4: 144-52
62. Metzger BE, Ravnikar V, Vileisis RA, Freinkel N. Accelerated starvation and the skipped breakfast in late normal pregnancy. Lancet 1982; 1: 588-92
63. Heindel JJ, Balbus J, Birnbaum L, et al. Developmental origins of health and disease: integrating environmental influences. Endocrinology 2015: EN20151394. [Epub ahead of print]. doi: http://dx.doi.org/10.1210/EN.2015-1394
64. Galliano D, Bellver J. Female obesity: short-And long-Derm consequences on the offspring. Gynecol Endocrinol 2013; 29: 626-31
65. Roseboom TJ, Watson ED. The next generation of disease risk: are the effects of prenatal nutrition transmitted across generations? Evidence from animal and human studies. Placenta 2012; 33 (Suppl 2): e40-4
66. Manco M, Dallapiccola B. Genetics of pediatric obesity. Pediatrics 2012; 130: 123-33
67. Vickers MH. Developmental programming and transgenerational transmission of obesity. Ann Nutr Metabol 2014; 64 (Suppl 1): 26-34
68. Attig L, Vige A, Gabory A, et al. Dietary alleviation of maternal obesity and diabetes: increased resistance to diet-induced obesity transcriptional and epigenetic signatures. PLoS One 2013; 8: e66816
69. Nicholas LM, Rattanatray L, MacLaughlin SM, et al. Differential effects of maternal obesity and weight loss in the periconceptional period on the epigenetic regulation of hepatic insulin-signaling pathways in the offspring. FASEB J 2013; 27: 3786-96
70. Zhang S, Rattanatray L, Morrison JL, et al. Maternal obesity and the early origins of childhood obesity: weighing up the benefits and costs of maternal weight loss in the periconceptional period for the offspring. Exp Diabetes Res 2011; 2011: 585749
71. Guenard F, Deshaies Y, Cianflone K, et al. Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proc Natl Acad Sci USA 2013; 110: 11439-44
72. Ge ZJ, Zhang CL, Schatten H, Sun QY. Maternal diabetes mellitus and the origin of non-communicable diseases in offspring: the role of epigenetics. Biol Reprod 2014; 90: 139-1-6
73. Dabelea D, Crume T. Maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 2011; 60: 1849-55
74. Stirrat LI, Reynolds RM. Effects of maternal obesity on early and long-Derm outcomes for offspring. Res Rep Neonatol 2014; 2014: 43-53
75. Heerwagen MJ, Miller MR, Barbour LA, Friedman JE. Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol 2010; 299: R711-22
76. Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011; 34: 1481-6
77. Van Gaal LF, Mertens IL, Ballaux D. What is the relationship between risk factor reduction and degree of weight loss? Eur Heart J Suppl 2005; 7 (Suppl L): L21-6
78. Racette SB, Deusinger SS, Deusinger RH. Obesity: overview of prevalence, etiology, and treatment. Phys Ther 2003; 83: 276-88
79. Tsai AG, Herring SJ, Jay M. CMS to reimburse for intensive obesity treatment in primary care: a step in the right direction. SGIM Forum 2012; 35: 1-2
80. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. J Am Coll Cardiol 2014; 63 (25 Pt B): 2985-3023
81. Dalle Grave R, Calugi S, Molinari E, et al. Weight loss expectations in obese patients and treatment attrition: an observational multicenter study. Obes Res 2005; 13: 1961-9
82. Savage JS, Fisher JO, Birch LL. Parental influence on eating behavior: conception to adolescence. J Law Med Ethics 2007; 35: 22-34
83. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-Analysis. Ann Intern Med 2013; 159: 758-69
84. Bays HE, González-Campoy JM, Henry RR, et al. Is adiposopathy (sick fat) an endocrine disease? Int J Clin Pract 2008; 62: 1474-83
85. Hanson MA, Gluckman PD. Developmental origins of health and disease-global public health implications. Best Pract Res Clin Obstet Gynaecol 2015; 29: 24-31